Bharat Biotech Submits Covaxin Phase 3 Trial Data; Expert Panel Meet Today

Bharat Biotech has submitted Phase III trial data for the Covaxin coronavirus vaccine to the DCGI (Drug Controller General of India), whose SEC (subject expert committee) is expected to meet later…

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!